Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hille

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 30, 2015
Left Ventricular Wall Stress-Mass-Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE StudyRichard B Devereux, Casper N Bang, Mary J Roman, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2008
Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension StudyIngrid Os, Veronica Franco, Sverre E Kjeldsen, et al.
Journal of Internal Medicine|September 19, 2007
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE studyE Fossum, G W Gleim, S E Kjeldsen, et al.
Circulation. Arrhythmia and Electrophysiology|October 8, 2009
Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE studyPeter M Okin, Kristian Wachtell, Sverre E Kjeldsen, et al.
Diabetes Care|April 30, 2003
Analysis of metabolic parameters as predictors of risk in the RENAAL studyGerald B Appel, Jai Radhakrishnan, Morrell M Avram, et al.
Vaccine|September 23, 2017
Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trialZhaojun Mo, Yi Mo, Mingqiang Li, et al.
The American Journal of Cardiology|August 28, 2007
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study)Marianne L Smebye, Emil K Iversen, Aud Høieggen, et al.
Virology|April 1, 1995
Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B)E Kremmer, B R Kranz, A Hille, et al.
JAMA|September 14, 2006
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertensionPeter M Okin, Kristian Wachtell, Richard B Devereux, et al.
JAMA|December 26, 2001
Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trialD A Morrow, C P Cannon, N Rifai, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Hypertension (Dallas, Tex. : 1979)|September 30, 2015
Left Ventricular Wall Stress-Mass-Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE StudyRichard B Devereux, Casper N Bang, Mary J Roman, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2008
Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension StudyIngrid Os, Veronica Franco, Sverre E Kjeldsen, et al.
Journal of Internal Medicine|September 19, 2007
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE studyE Fossum, G W Gleim, S E Kjeldsen, et al.
Circulation. Arrhythmia and Electrophysiology|October 8, 2009
Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE studyPeter M Okin, Kristian Wachtell, Sverre E Kjeldsen, et al.
Diabetes Care|April 30, 2003
Analysis of metabolic parameters as predictors of risk in the RENAAL studyGerald B Appel, Jai Radhakrishnan, Morrell M Avram, et al.
Vaccine|September 23, 2017
Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trialZhaojun Mo, Yi Mo, Mingqiang Li, et al.
The American Journal of Cardiology|August 28, 2007
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study)Marianne L Smebye, Emil K Iversen, Aud Høieggen, et al.
Virology|April 1, 1995
Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B)E Kremmer, B R Kranz, A Hille, et al.
JAMA|September 14, 2006
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertensionPeter M Okin, Kristian Wachtell, Richard B Devereux, et al.
JAMA|December 26, 2001
Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trialD A Morrow, C P Cannon, N Rifai, et al.
Pageof 12